These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 983071)

  • 1. [A comparative study of the kinetics of 131I-bromsulphthalein and 125 I-biligrafin (author's transl)].
    Mostbeck A; Peschl L; Sponer D
    Wien Klin Wochenschr; 1976 Oct; 88(19):627-30. PubMed ID: 983071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatic handling of 131I-labeled sulfobromophthalein in the dog. Comparison with sulfobromophthalein.
    Glasinovic JC; Delage Y; Erlinger S
    Biomedicine; 1976 Sep; 25(7):255-8. PubMed ID: 990386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I-BSP kinetics in the liver and its application for various liver diseases (author's transl)].
    Nishimura T; Suematsu T; Hori M; Kimura K
    Rinsho Byori; 1977 Jul; 25(7):582-6. PubMed ID: 916245
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kinetics and metabolism of i.v. injected bromsulphthalein (BSP) in man].
    Klapdor R; Roose HJ
    Z Gastroenterol; 1971; 9(9):665-72. PubMed ID: 5154047
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of tauroursodeoxycholate on the biliary transport maximum of sulfobromophthalein in the rat.
    Kanai S; Kitani K
    J Lab Clin Med; 1986 Dec; 108(6):601-7. PubMed ID: 3783030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine effects on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    J Pharmacol Exp Ther; 1985 Nov; 235(2):393-7. PubMed ID: 4057076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and metabolism of 125I-sulfobromophthalein.
    Hirano M; Theilmann L; Stollman YR; Sosiak A; Wolkoff AW
    Clin Chim Acta; 1983 Mar; 128(2-3):321-7. PubMed ID: 6851140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution kinetics of 35S-BSP and 131-I-BR in subjects with healthy livers].
    Uthgenannt H; Adlung J; Schoregge J
    Z Gastroenterol; 1973 Jan; 11(1):3-10. PubMed ID: 4803407
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of sulfobromophthalein (BSP) and sulfobromophthalein glutathione (BSP-GSH) disposition under conditions of altered liver function and in the isolated perfused rat liver.
    Yam J; Reeves M; Roberts RJ
    J Lab Clin Med; 1976 Mar; 87(3):373-83. PubMed ID: 1249471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.
    Häcki W; Bircher J; Preisig R
    J Lab Clin Med; 1976 Dec; 88(6):1019-31. PubMed ID: 993641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can we do without the bromsulphthalein-(BSP-)test in diagnosis of liver disease? (author's transl)].
    Sundal E
    Schweiz Rundsch Med Prax; 1981 Feb; 70(9):329-33. PubMed ID: 7208430
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of cholic acid and dehydrocholic acid on the biliary excretion of unconjugated and conjugated sulfobromophthalein in rats.
    Schulze PJ; Czok G; Meyer H
    Arzneimittelforschung; 1976; 26(10):1894-903. PubMed ID: 1037210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sulfobromophthalein and indocyanine green clearances in the cat.
    Center SA; Bunch SE; Baldwin BH; Hornbuckle WE; Tennant BC
    Am J Vet Res; 1983 Apr; 44(4):727-30. PubMed ID: 6869973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal biliary transport of sulfobromophthalein in patients with a T-tube placed in the common bile duct.
    Serra MA; Caballero A; Del Olmo JA; Aparisi L; Gilabert MS; Rodríguez F; Escudero A; Wassel A; Ferrando J; Reig G; Rodrigo JM
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):135-9. PubMed ID: 9248781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
    Zhao Y; Snel CA; Mulder GJ; Pang KS
    Drug Metab Dispos; 1993; 21(6):1070-8. PubMed ID: 7905386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary transport of cholephilic dyes: evidence for two different pathways.
    Mahu JL; Duvaldestin P; Dhumeaux D; Berthelot P
    Am J Physiol; 1977 May; 232(5):E445-50. PubMed ID: 871154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of hepatobiliary diseases by the evaluation of bromsulfophthalein blood kinetics.
    Molino G; Milanese M; Villa A; Cavanna A; Gaidano GP
    J Lab Clin Med; 1978 Mar; 91(3):396-408. PubMed ID: 627746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of portocaval shunt on bile flow and maximal biliary excretion of bromsulfophthalein sodium (BSP) in rats with thioacetamide induced liver cirrhosis.
    Bodnár A; Karácsonyi S; Zsigmond G
    Z Exp Chir; 1981 Feb; 14(1):35-9. PubMed ID: 7234017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrahpetic distribution of sulfobromophthalein.
    Klaassen CD
    Can J Physiol Pharmacol; 1975 Feb; 53(1):120-3. PubMed ID: 1139436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.